ANVISA registration 81062710048Valid until Aug 08, 2032NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1)
ANVISA Registration Number: 81062710048Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltdaCEPHEID ABRisk Class IV
Device names
- Technical name
- NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1)
- Risk class
- Class IV
PT: ÁCIDO NUCLÉICO DE VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 (HIV 1)
Registration details
- Registration Number
- 81062710048
- Process Number
- 25351924481202124
- CNPJ
- 18628083000123
Company information
- Registration Holder
- Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda
- Manufacturer
- CEPHEID AB
- Manufacturing Country
- Sweden
PT: SUÉCIA
Dates and status
- Publication Date
- Aug 08, 2022
- Validity
- 08/08/2032
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81062710048 and manufactured by CEPHEID AB. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Aug 08, 2032.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.